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Chk1 protein kinase maintains replication fork stability in metazoan cells in response to DNA damage and
DNA replication inhibitors. Here, we have employed DNA fiber labeling to quantify, for the first time, the extent
to which Chk1 maintains global replication fork rates during normal vertebrate S phase. We report that
replication fork rates in Chk1/ chicken DT40 cells are on average half of those observed with wild-type cells.
Similar results were observed if Chk1 was inhibited or depleted in wild-type DT40 cells or HeLa cells by
incubation with Chk1 inhibitor or small interfering RNA. In addition, reduced rates of fork extension were
observed with permeabilized Chk1/ cells in vitro. The requirement for Chk1 for high fork rates during
normal S phase was not to suppress promiscuous homologous recombination at replication forks, because
inhibition of Chk1 similarly slowed fork progression in XRCC3/ DT40 cells. Rather, we observed an
increased number of replication fibers in Chk1/ cells in which the nascent strand is single-stranded,
supporting the idea that slow global fork rates in unperturbed Chk1/ cells are associated with the accumu-
lation of aberrant replication fork structures.
The stability of cellular genomes is maintained in part by cell
cycle-specific and DNA structure-specific checkpoints (14, 21).
The transducer/effector protein kinases Chk1 and Chk2 have
received considerable attention in recent years due to their
central role in regulating aspects of cell cycle progression and
chromosome metabolism in response to genotoxic stress. In
metazoans, deletion or depletion of the Chk1 gene or protein
prevents or reduces the delay into mitosis normally imposed
in response to DNA damage or if replication is inhibited or
blocked (4, 6, 15, 16, 23, 25, 27, 29). Chk1 is also required in
metazoans to inhibit origin firing and maintain the stability/
viability of stalled replication forks in response to DNA dam-
age or replication inhibitors (5, 26, 27).
In addition to its roles in the response to exogenous cellular
stress, Chk1 plays a critical role during normal proliferation
because disruption of Chk1 is embryonic lethal in mice and
fruit flies and is cell lethal in mouse embryonic stem cells (6,
16, 25). Disruption of Chk1 in chicken DT40 cells is not cell
lethal but does confer a pronounced slow-growth phenotype
(26). The critical function of Chk1 in unperturbed cells is
unclear, but inhibition or depletion of Chk1 has been reported
to deregulate origin firing during unperturbed S phase in hu-
man cells, leading to elevated levels of single-stranded DNA
and DNA breakage (24).
Given that Chk1 is required to maintain replication fork
stability in response to DNA replication inhibitors or exoge-
nous DNA damage in metazoans, we considered the possibility
that Chk1 may also be required during a normal S phase to
facilitate fork progression beyond endogenous lesions or other
types of replication fork barrier. Consistent with this idea, the
ATR protein kinase that activates Chk1 in response to repli-
cation inhibitors or exogenous DNA damage is required for
the stability of fragile sites (1). In addition, caffeine, an inhib-
itor of ATR and ATM, slows replication fork rates in isolated
Xenopus laevis sperm nuclei (20). However, whether or not
Chk1 is required to maintain normal replication fork rates in
metazoans has not been examined. Moreover, it is unclear how
global any requirement for Chk1 for the progression of repli-
cation forks in metazoans might be, given that the number of
impediments encountered by replication forks during a normal
S phase is unknown.
Here, we have employed a DNA fiber-labeling technique to
measure directly the impact of Chk1 on the rate of replication
fork progression during normal vertebrate S phase. Strikingly,
we report that loss of vertebrate Chk1 reduces global fork rates
by half, indicating that Chk1 is a bona fide DNA replication
protein that is required for the normal progression of most if
not all replication forks.
MATERIALS AND METHODS
Chromatin fiber experiments. For dual labeling of replication tracts, exponen-
tial cell cultures of wild-type DT40 cells (clone 18), Chk1/ DT40 cells (26, 27),
Chk2/ DT40 cells (27), or HeLa cells were pulse-labeled with 25 M BrdU for
15 to 20 min followed by 250 M IdU for 25 to 30 min, as indicated. For single
labeling, exponential cell cultures were pulse-labeled with either BrdU or IdU
for 45 to 60 min at the concentrations indicated. Where appropriate, cells were
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pretreated with the Chk1 inhibitor UCN-01 (Drug Synthesis and Chemistry
Branch, Developmental Therapeutics Program, Division of Cancer Treatment
and Diagnosis, National Cancer Institute, Bethesda, MD) at 300 nM for 1 h prior
to labeling and then throughout. To knock down human Chk1, we employed
small interfering RNA (siRNA) duplex oligonucleotides (Invitrogen) directed
against the Chk1 target sequence (sense) UCGUGAGCGUUUGUUGAAC
(30). siRNA duplexes (10 nM) were transfected using siPORT NeoFX reverse
transfection reagent (Ambion) according to the manufacturer’s protocol. After
48 h, cells were labeled as described above. Labeled cells were harvested and
DNA fiber spreads prepared as previously described (11). For immunodetection
of BrdU-labeled tracts, acid-treated fiber spreads were incubated with rat anti-
BrdU monoclonal antibody (Oxford Biotechnology) at a 1:1,000 dilution for 1 h
at room temperature. Slides were then fixed with 4% paraformaldehyde and
incubated with AlexaFluor 488-conjugated donkey anti-rat immunoglobulin G
(IgG) (Molecular Probes) at 4 g/ml for 1.5 h at room temperature. To detect
both BrdU- and IdU-labeled patches, a sheep polyclonal antibody that recog-
nizes both IdU and BrdU (Biodesign International) was employed at 2 g/ml
overnight at 4°C, followed by a Cy3-conjugated donkey anti-sheep IgG (Jackson
Immunoresearch) at 2.5 g/ml for 1.5 h at room temperature. Fibers were
examined using a Zeiss LSM 510 confocal microscope using a 100 (1.4-numer-
ical-aperture) lens, and the lengths of green (AlexaFluor 488)- and/or red (Cy3)-
labeled patches were measured using the LSM software. Measurements were
recorded from fibers in well-spread (untangled) areas of the slides to prevent the
possibility of recording labeled patches from bundles of fibers.
Agarose cell beads and chromosome replication. [3H]thymidine-labeled cells
(3  107) were suspended in 3 ml of 0.5% low-melting-point agarose in
phosphate-buffered saline (PBS). The cell suspension was overlaid with 2 vol-
umes of mineral oil and mixed vigorously on a vibrating shaker (IKA-VIBRAX-
VXR) at full speed before being cooled on ice. Washed cell beads were then
incubated in complete medium (37°C) for 2 h to allow cell recovery and resus-
pended in physiological buffer (100 mM potassium acetate, 30 mM KCl, 10 mM
Na2HPO4, 1 mM MgCl2, 1 mM Na2ATP, 1 mM dithiothreitol, and 200 M
phenylmethylsulfonyl fluoride, pH 7.4) supplemented with 50 mg/ml fatty acid-
free bovine serum albumin (Sigma-Aldrich) and 300 g/ml saponin (Sigma-
Aldrich). After permeabilization for 8 min, washed cell beads were resuspended
in physiological buffer with bovine serum albumin. For measurement of replica-
tion rates, aliquots were mixed with 10 replication mix (10 mM MgCl2; 20 mM
KPO4 [pH 7.4]; 1 mM each of CTP, GTP, and UTP; 2.5 mM each of dGTP,
dCTP, and dATP; 250 M TTP; 200 mM creatine phosphate; 1 mg/ml creatine
kinase) and 30 Ci [-32P]TTP (3,000 Ci/mmol; Amersham-Pharmacia). Reac-
tions were incubated at 37°C and stopped at the indicated times by the addition
of sodium dodecyl sulfate (SDS). 3H and 32P counts were quantified via liquid
scintillation, and 32P counts were normalized for cell number by using the 3H
counts and converted to pmol TTP incorporated/106 cells. For measuring the
percentages of cells in S phase, aliquots were mixed with 10 replication mix as
described above but containing 30 M digoxigenin-11–dUTP (Roche) instead of
TTP. Reactions were incubated at 37°C for 30 min, and washed beads were fixed
with 4% paraformaldehyde. Digoxigenin-11–dUTP replication foci were immu-
nolabeled with fluorescein isothiocyanate-conjugated antidigoxigenin Fab frag-
ment (1.5 h, 30 g/ml; Roche), and nuclei were counterstained with DAPI
(4,6-diamidino-2-phenylindole). S-phase cells were quantified using a Leitz
Diaplan microscope.
Immunoblotting. For immunoblotting, harvested cells were lysed in SDS load-
ing buffer and lysates from 3  105 to 6  105 cells per lane were resolved by
SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose mem-
branes. Total Chk1 was detected using rabbit polyclonal anti-Chk1 antibody
(Santa Cruz Biotechnology) at 4 g/ml, and Chk1 phosphorylated at Ser345
(phospho-Chk1 Ser345) was detected using rabbit polyclonal anti-phospho-Ser345
antibody at a 1:1,000 dilution (New England Biolabs).
Detection of single-stranded nascent DNA by immunofluorescence. Wild-type
(clone 18) and Chk1/ DT40 cells at 5  105 cells/ml were incubated with 25
M BrdU for 20 min. Cells were then washed three times in cold PBS, and 5 
105 cells were swollen in 0.075 M KCl for 15 min at 37°C, as previously described
(11). Cells were then fixed with methanol-acetic acid (3:1), dropped onto washed
microscope slides, and air dried. Slides were acid treated and incubated with
sheep anti-BrdU antibody (M20105S; Biodesign) at 4 g/ml for 1 h and then
Cy3-conjugated donkey anti-sheep IgG (Jackson Immunoresearch) at 2.5 g/ml
for 1 h. Nuclei were counterstained with 5 g/ml Hoechst 33258 (Sigma). For
detection of incorporated BrdU in the absence of HCl denaturation, fixed slides
were stored at 4°C for several weeks before immunostaining.
For direct labeling of replication tracts with biotin-11–dUTP (Yorkshire Bio-
science), cells were washed in cold PBS (3) and 1  106 cells in 10 l of PBS,
transfected with biotin-11–dUTP analogue (1 l of 50 nM solution) by using
FuGene (Roche), and then washed in fresh medium and incubated for 30 min at
37°C. Cells were additionally pulse-labeled with 25 M BrdU for 20 min either
before or after transfection with biotin-11–dUTP. Biotin-11–dUTP was detected
using an antibiotin mouse monoclonal antibody (clone BN-34; Sigma) at a
1:1,000 dilution.
RESULTS
Wild-type chicken DT40 cells or DT40 cells lacking the
protein kinase Chk1 (26, 27) or Chk2 (27) were pulse-labeled
for 20 min with 25 M BrdU followed by 250 M IdU for 25
to 30 min, and the length of the labeled DNA replication tracts
in DNA fiber spreads was then quantified by indirect immu-
nofluorescence. Dual labeling in this way enables unambiguous
identification of replication tracts arising from individual rep-
lication forks and establishes their directionality. A visual com-
parison of DNA fibers from wild-type and Chk1/ DT40 cells
revealed a striking difference in the overall lengths of their
replication tracts (Fig. 1A). This difference was also evident
when the distribution of fork rates within populations of forks
was quantified and plotted, with the entire distribution of fork
rates in Chk1/ cells shifted leftwards, to slower fork rates,
during both pulse-labels (Fig. 1B). These data suggest that
most if not all replication forks progress in Chk1/ cells at a
slower rate than in wild-type cells. In contrast, we did not
observe any replication defect in Chk2/ DT40 cells, which
displayed rates of fork progression similar to that for wild-type
DT40 (Fig. 1C).
We noted in the experiments described above that the differ-
ence in fork rate distribution between wild-type and Chk1/
cells was greater during the second pulse-label, employing IdU,
than during the first pulse-label, employing BrdU (Fig. 1A and
B). Consequently, to examine whether the slow fork rates in
Chk1/ cells were an artifact of employing halogenated
nucleosides, we compared the impact of a wide range of BrdU
and IdU concentrations on fork rates in experiments in which
each of the two halogenated deoxyribonucleosides was em-
ployed separately. The extents of fork slowing in Chk1/ cells
were similar in single-label experiments at concentrations of
BrdU (Fig. 2A) or IdU (Fig. 2B) ranging from 5 M to 250
M, suggesting that the slow fork rate in Chk1/ cells is
unrelated to the use of halogenated nucleosides. Similar ex-
periments revealed that fork rates in wild-type cells were sim-
ilarly unaffected by concentration of BrdU or IdU and were on
average twofold faster than the mean fork rate in Chk1/
cells at all concentrations examined (Fig. 2C and D). To fur-
ther rule out that the labeling protocol did not itself induce a
requirement for Chk1 activity, we examined the phosphoryla-
tion status of Chk1 (13). The level of signal present on anti-
phospho-Chk1 Ser345 immunoblots was no greater for cells
subjected to dual labeling than the basal level observed for
cells that were not subjected to dual labeling, confirming that
pulse-labeling does not itself trigger Chk1 activation (16, 18)
(Fig. 2E). The basal signal detected in these experiments re-
flected true phospho-Chk1 Ser345 because it was not observed
in cell extract from Chk1/ cells or Chk1/ cells harboring
nonphosphorylatable Chk1S345A protein (data not shown). We
conclude from these experiments that the slow fork rate ob-
served with Chk1/ cells is not related to the use of haloge-
nated nucleosides but rather that Chk1 is required for high
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global rates of replication fork progression during unperturbed
S phase.
To examine whether the protein kinase activity of Chk1
might be required for its role in maintaining normal fork rates,
we examined whether the Chk1 inhibitor UCN-01 (7) also
slowed replication fork progression. Indeed, coincubation with
UCN-01 during pulse-labeling significantly reduced the rate of
replication fork progression in wild-type DT40 cells (Fig. 3A).
The impact of UCN-01 was largely Chk1 dependent in these
experiments, because the inhibitor had relatively little impact
on fork rates in Chk1/ DT40 cells (data not shown). In
addition, the slower fork rates observed with cells lacking Chk1
activity was not due to tonic activation of Chk2, because
UCN-01 still decreased fork speeds in Chk2/ cells (data not
shown). Importantly, UCN-01 also reduced replication fork
rates in HeLa cells, suggesting that Chk1 is also required for
normal global fork rates in human cells (Fig. 3B). This notion
was confirmed by experiments in which Chk1 was depleted in
HeLa cells by use of siRNA, in which we again observed
reduced global rates of replication fork progression (Fig. 3C).
We next examined whether the requirement for Chk1 for
maintaining high fork rates during normal S phase could be
recapitulated in vitro. We thus employed a fork extension assay
in which cells are encapsulated in agarose microbeads, perme-
abilized, and then incubated in a physiological buffer contain-
ing exogenous deoxynucleoside triphosphates (9, 10, 12). To
enable us to normalize the rate of deoxynucleoside triphos-
phate incorporation for the fraction of cells in S phase, aliquots
of encapsulated cells were labeled with digoxigenin-11–dUTP
and DAPI in parallel (Fig. 4A). Remarkably, these experi-
FIG. 1. Replication fibers and fork rates in wild-type (WT) and Chk1/ chicken DT40 cells. (A) Representative images of replication tracts
from wild-type and Chk1/ DT40 cells pulse-labeled with 25 M BrdU for 20 min (yellow track) followed by 250 M IdU for 30 min (red track)
and then processed for DNA fiber spreads as described in Materials and Methods. Fork direction is indicated by a black arrow, and the junction
between pulse-labels is indicated by a white arrow. (B) Distribution of replication fork rates in wild-type and Chk1/ DT40 cells pulse-labeled
and processed as described above. (C) Distribution of replication fork rates in wild-type and Chk2/ DT40 cells. For each panel, the distribution
of fork rates during the first (BrdU) and second (IdU) pulse-labels is shown. Data bars are the means of three independent experiments, with
similar results observed for each, and error bars represent 1 standard deviation. The total number of forks scored for each distribution is indicated
in parentheses.
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ments revealed that permeabilized Chk1/ cells exhibit initial
fork extension rates that are 60% of those observed with
wild-type cells (Fig. 4B), confirming that the slower rates of
fork progression observed with intact cells are also evident in
vitro.
We have reported previously that rates of fork progression
are actively slowed in the presence of UV or cisplatin damage
by homologous recombination (HR), due most likely to the
time taken for HR reactions during DNA replication (8). We
thus considered the possibility that Chk1 might maintain nor-
mal rates of fork progression during unperturbed S phase by
inhibiting or preventing unnecessary HR reactions at paused
or stalled forks, thereby minimizing delays in fork progression.
To address this question, we compared the effect of UCN-01
on fork progression rates in wild-type and XRCC3/ (HR-
defective) DT40 cells. We reasoned that if Chk1 does maintain
high fork rates by suppressing HR, then it should be redundant
in cells that lack HR. However, UCN-01 triggered fork slowing
in both wild-type and XRCC3/ DT40 cells (Fig. 5), suggest-
ing that the requirement for Chk1 for normal fork rates during
unperturbed S phase is not suppression of HR. Once again, we
noted in these experiments that the apparent influence of Chk1
on fork rate was greater during the second pulse-label than
during the first.
In Saccharomyces cerevisiae, Rad53 is required to prevent
the formation of replication fork intermediates that contain
extensive regions of single-stranded DNA during hydroxyurea
treatment (17). Consistent with Chk1 perhaps fulfilling a sim-
ilar role in vertebrates, Chk1 inhibition has similarly been
shown to result in increased levels of single-stranded DNA in
human cells (24). However, because cells were labeled with
BrdU for 24 h in these experiments, it is not clear whether the
single-stranded DNA was located near replication forks. To
examine this question directly, we fixed cells immediately after
a short pulse-label (20 min) with BrdU and then immuno-
stained with anti-BrdU antibodies in the absence of DNA
denaturation. Whereas incorporated BrdU was detected in
wild-type DT40 cells only if DNA was first denatured with HCl,
BrdU was detected in large numbers of Chk1/ cells even in
the absence of denaturation (Fig. 6A). We noted that storing
of fixed slides for several weeks at 4C was necessary to unveil
incorporated BrdU in Chk1/ cells in the absence of HCl,
presumably to enable dissociation of replication protein A
from the single-stranded DNA. We also note that, because of
the very short pulse-labeling period employed in these exper-
iments, the single-stranded DNA observed here was comprised
of nascent strands.
To further colocalize the single-stranded DNA with DNA rep-
lication forks, we immunostained chromosome fiber spreads in
the absence of HCl denaturation (Fig. 6B). To achieve this, we
pulse-labeled replication forks with BrdU for 20 min followed
by biotin-11–dUTP for 30 min to tag the forks. These experi-
FIG. 2. Impact of BrdU and IdU on replication fork rates and
Chk1 Ser345 phosphorylation in vertebrate cells. (A) Fork rates in
Chk1/ DT40 cells incubated with 5 to 250 M BrdU for 60 min. The
total number of forks scored for each distribution is indicated in
parentheses. (B) Fork rates in Chk1/ DT40 cells incubated with 5 to
250 M IdU for 60 min. (C) Comparison of fork rate distributions
obtained for Chk1/ cells and wild-type (WT) DT40 cells incubated
with 250 M BrdU or 250 M IdU for 45 to 60 min. (D) Tabulated
average fork rates for Chk1/ and wild-type DT40 cells incubated
with 5 to 250 M BrdU or IdU. Mean fork rates are calculated from
the data shown in panels A and B and are from one experiment for
each deoxyribonucleoside. Note that the standard deviation (SD) val-
ues reflect the intrinsic variation in progression rates of different rep-
lication forks. conc., concentration. (E) Levels of total Chk1 and phos-
pho-Chk1 Ser345 (Chk1-PS345) in wild-type DT40 cells mock labeled
() or dually labeled (label) with BrdU (20 min) followed by IdU (30
min) or incubated with 20 M aphidicolin (aphid) for 240 min as a
positive control for Chk1 phosphorylation.
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ments revealed the presence of three- to fivefold more repli-
cation tracts containing single-stranded DNA in Chk1/ cells
than in wild-type cells and identified the nascent DNA strands
as components of the single-stranded material. Together, these
data associate the reduced global fork rates in cells lacking
Chk1 protein or activity with the accumulation of abnormal
DNA replication structures.
DISCUSSION
Chk1 is required in metazoans in response to DNA damage
or replication inhibitors to maintain replication fork stability,
suppress unscheduled firing of replication origins, and prevent
premature entry into mitosis (4–6, 15, 16, 23, 25–27, 29). How-
ever, Chk1 also fulfills a role during the proliferation of un-
perturbed cells because disruption of Chk1 is embryonic lethal
in mice and fruit flies and is cell lethal in cultured mouse
embryonic stem cells (6, 16, 25). In addition, Chk1/ chicken
DT40 cells exhibit increased doubling times and elevated fre-
quencies of apoptosis (26). One role for Chk1 in unperturbed
cells is the suppression of futile or late replication origins (22,
24), and it has been suggested that loss of this function and the
consequent increase in DNA replication result in increased
chromosome breakage (24).
Here, we demonstrate that Chk1 is also required to maintain
high global rates of replication fork progression during normal
S phase. It is unlikely that the impact of Chk1 on fork rates is
an indirect effect of the elevated level of apoptosis and reduced
growth rate reported to occur in these cells (26). This is be-
cause we observed fork slowing even during short incubations
with Chk1 inhibitor and thus in the absence of any detectable
cell death or impact on overall cell cycle distribution. In addi-
FIG. 3. Impact of the Chk1 inhibitor UCN-01 on replication fork rates in wild-type (WT) DT40 and HeLa cells. (A) Distribution of replication
fork rates in wild-type DT40 cells pulse-labeled with 25 M BrdU for 20 min followed by 250 M IdU for 30 min in the absence or presence of
300 nM UCN-01. (B) Distribution of replication fork rates in HeLa cells pulse-labeled for 15 to 20 min in BrdU followed by 20 to 25 min in IdU
in the absence or presence of 300 nM UCN-01. (C) Distribution of replication fork rates in mock-treated or Chk1 siRNA-treated HeLa cells
pulse-labeled as described for panel B. (Inset) Chk1 and actin levels in total cell extract from mock-treated or Chk1 siRNA-treated (siR) HeLa
cells. In panels A and C, data are the means of three independent experiments and error bars represent 1 standard deviation. In panel B, data from
two independent experiments are combined. For each data set, similar results were observed in each experimental repeat. The total number of
forks scored for each cell line is indicated in parentheses.
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tion, in experiments in which we employed consecutive pulse-
labeling with BrdU and IdU to label each replication tract, we
consistently observed a greater impact of Chk1 deletion or
inhibition during the second pulse-label. This differential im-
pact of Chk1 within individual replication forks is unlikely to
be attributable to an indirect effect of Chk1 on cell growth or
cell cycle distribution.
A role for Chk1 in maintaining replication fork progression
FIG. 4. Replication fork rates in permeabilized wild-type (WT) and Chk1/ DT40 cells in vitro. (A) Wild-type and Chk1/ cells were
encapsulated in agarose microbeads and permeabilized, and aliquots were then pulse-labeled for 30 min with digoxigenin-11–dUTP. Agarose beads
were stained with DAPI to identify nuclei and with fluorescein isothiocyanate (FITC)-tagged antidigoxigenin (anti-Dig) antibody to identify
S-phase cells. The fraction of S-phase cells in each population was calculated from multiple microscopic fields and used to normalize replication
fork rates, as shown in panel B. The fractions of cells in S phase were 43% (	3%) and 24% (	4%) for wild-type and Chk1/ cells, respectively.
Note that a single agarose bead is present in the top panels and two are present in the bottom panels. (B) Replication fork rates were quantified
in permeabilized wild-type and Chk1/ cells encapsulated in agarose microbeads, as described in Materials and Methods, in the presence of
[32P]TTP. Results are the means of three independent experiments, with error bars representing 1 standard deviation.
FIG. 5. Replication fork rates in DT40 cells lacking both Chk1 activity and HR capacity. (A) Wild-type (WT) and XRCC3/ DT40
cells were pulse-labeled with 25 M BrdU for 20 min followed by 250 M IdU for 30 min in the absence or presence of UCN-01 (300
nM) and then processed for DNA fiber spreads. Results are combined from two independent experiments with the same result
observed in each. The total numbers of forks scored are indicated in parentheses.
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during normal S phase has not been demonstrated previously.
However, such a role is consistent with previous reports that
ATR, a protein kinase that activates Chk1, is required for the
stability of endogenous chromosomal fragile sites in mamma-
lian cells (1) and for normal replication fork rates in isolated
Xenopus sperm nuclei (20). In addition, termination of Chk1-
mediated checkpoints may be facilitated by a feedback mech-
anism involving Chk1 polyubiquitination and degradation that
is triggered once Chk1 is activated by phosphorylation at S345
(28). Since Chk1 polyubiquitination appears to occur even in
unperturbed cells, it seems likely that Chk1 is active during
normal S phase, a notion supported by our observation of
low levels of phospho-Chk1 Ser345 in unperturbed DT40 cells
(Fig. 2E).
Strikingly, the average rate of replication fork progression
during a single 60-min pulse-label dropped by half in the ab-
sence of Chk1, from1.2 kb/min to 0.6 kb/min, suggesting that
Chk1 is routinely required by most if not all replication forks
during a normal vertebrate S phase. This conclusion is sup-
ported by a comparison of the fork rate distributions for wild-
type and Chk1/ cells, in which the majority of the replication
forks in Chk1 populations shifted leftwards to slower rates
(e.g., see Fig. 2C). Consequently, we conclude that Chk1 is a
bona fide DNA replication protein, the activity of which is
required by most if not all replication forks.
Despite their slow rate of fork progression, the cell cycle of
Chk1/ cells is not lengthened (26). This suggests that the
decrease in fork rate in Chk1/ cells may be compensated for
by an increase in the number of active origins. Increased origin
activation has been observed to occur in metazoans in the
absence of ATR/ATM activity (22) and in Chk1-depleted or
-inhibited cells following chemical perturbation (5, 24, 26).
Also, we observed greater numbers of bidirectional, recently
initiated replication forks in Chk1/ cells than in wild-type
cells, supporting the presence of increased numbers of active
origins (data not shown). We also frequently observed single
fibers that contained multiple bidirectional forks in close prox-
imity in Chk1/ cells. However, despite the increase in num-
ber of active origins, we still observed an overall reduction in
the level of nucleotides incorporated into permeabilized Chk1
cells in vitro. This would not be expected if the reduced fork
rate in Chk1/ cells were compensated for by increased fork
numbers. Perhaps the compensatory activation of secondary
origins in living cells is most pronounced towards the end of S
phase, once the time allotted to complete replication using the
primary origins has expired, whereas our in vitro experiments
employed asynchronous populations of permeabilized cells dis-
tributed throughout S phase.
What is the role of Chk1 at replication forks during a normal
S phase? One possibility is that Chk1 promotes the activity of
one or more components of the replication machinery, such
that the replisome translocates more slowly in Chk1/ cells.
However, if this were true, then loss of Chk1 should have
affected fork rates to a similar extent during the two pulse-
labels of our dual-labeling protocol, whereas in fact the appar-
ent impact of Chk1 was greatest during the second pulse-label.
A more likely explanation for our data is that Chk1 is required
to maintain the stability of most if not all replication forks
during normal S phase. Such a role would be analogous to its
role following cellular exposure to genotoxins or replication
FIG. 6. Accumulation of single-stranded nascent DNA in Chk1/
DT40 cells. (A) Wild-type (WT) or Chk1/ DT40 cells were pulse-
labeled with BrdU for 20 min, fixed, and then either denatured with
HCl and immunostained with anti-BrdU antibodies (HCl) or stored
at 4°C before immunostaining in the absence of HCl denaturation
(HCl). Representative images of multiple cells are presented. Where
evident, cells were counterstained with Hoechst to identify nuclei.
(B) Wild-type or Chk1/ DT40 cells were pulse-labeled for 20 min with
BrdU (green) followed by transfection for 30 min in the presence of
biotin-11–dUTP (red). Samples were then processed for DNA fiber
spreads in the absence (top micrographs) or presence (bottom micro-
graphs) of HCl denaturation. The fractions of biotin-labeled forks (n 

164 wild-type forks; n
 142 Chk1/ forks) that stained with anti-BrdU
(-BrdU) antibody in the absence of HCl denaturation are shown
graphically. Data are from a single experiment. White arrows indicate
the direction of fork movement. In the case of forks in which only the
biotin label is visible, directionality is indicated by tailing of the fluo-
rescent signal, due to exhaustion of the transfected biotin-11–dUTP.
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inhibitors and could explain why the apparent impact of Chk1
was greatest during the second pulse-label. Because we scored
only those forks that incorporate both labels during the dual-
labeling protocol, forks that stalled irreversibly or for pro-
longed periods during the first pulse-label and which were thus
not active during the second pulse-label were not scored. In
contrast, all forks that stalled during the second label, no mat-
ter how prolonged or severe the stalling event, were scored
because these forks were already dually labeled. Consequently,
a role for Chk1 in maintaining global fork stability would have
a greater apparent impact on rates during the second pulse-
label than during the first, which is what we observed.
It is currently unclear why the stability of replication forks
might be threatened so frequently during normal S phase.
However, chromosomes are known to contain fragile sites and
replication slow zones that require checkpoint proteins for
their stability (1, 2). In addition, other physiological sources of
replication blockage during a normal S phase are endogenous
lesions and regions of the genome containing repetitive se-
quences, extensive secondary structure, or nucleoprotein com-
plexes. The mechanism by which Chk1 might stabilize replica-
tion forks is also unclear. In budding yeast, checkpoint proteins
are required to maintain the presence of DNA polymerase 
and ε at the replisome in response to hydroxyurea (3, 19),
though whether they fulfill a similar role in unperturbed cells is
not known. In budding yeast, the intra-S-phase checkpoint is
required during hydroxyurea treatment to prevent the forma-
tion of replication fork intermediates containing extensive re-
gions of single-stranded DNA (17). Recently, single-stranded
DNA was also observed to accumulate in human cells incu-
bated with Chk1 inhibitor (24). Our finding that Chk1 is re-
quired to suppress the occurrence of single-stranded nascent
DNA extends this observation and provides a possible expla-
nation for the slow global rates of replication fork progression
in cells lacking Chk1 during normal vertebrate S phase.
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